Enzymotec Ltd. ENZY
No live quote for ENZY yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 11.90
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.10 | 0.0% | 13.55M | +28.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.03 | 0.0% | 13.51M | +12.6% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 52.93M | +11.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 57.47M | +8.6% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 16, 2016 | Wells Fargo | Downgrade | — | Market Perform |
| Aug 12, 2015 | Wells Fargo | Upgrade | — | Outperform |
| Aug 5, 2014 | Wells Fargo | Downgrade | — | Market Perform |
| Dec 10, 2013 | Bank of America | Downgrade | — | Underperform |
| Oct 21, 2013 | Bank of America | Initiated | — | Buy |
| Oct 21, 2013 | Canaccord Genuity | Initiated | — | Buy |
| Oct 21, 2013 | Jefferies | Initiated | — | Hold |
| Oct 21, 2013 | Wells Fargo | Initiated | — | Outperform |
| Oct 21, 2013 | Wedbush | Initiated | — | Outperform |